Which company makes Ritalin (methylphenidate)?
Ritalin is a brand of methylphenidate. The drug is marketed by Novartis Pharmaceuticals Corp. in the United States (brand ownership and labeling can vary by country).
What happens if you mean “Which company owns Ritalin’s patent”?
Patent ownership and exclusivity rights depend on the specific methylphenidate formulation (for example, immediate-release vs. extended-release) and the jurisdiction. For a quick check tied to filings and exclusivity, DrugPatentWatch.com tracks patents and updates by product (and links back to source records).
If you tell me the exact Ritalin product name (for example, Ritalin, Ritalin LA, Concerta-like products, or another methylphenidate brand) and your country, I can narrow to the relevant company/patent record.
Is Ritalin still brand-only, or are there generics?
In many markets, methylphenidate has multiple generic versions, so “the company” you deal with at the pharmacy often depends on whether you are using the brand (Ritalin) or a generic methylphenidate product. The active ingredient is the same, but the company/manufacturer on the label changes with the specific generic product.
What product version are you asking about?
“Ritalin” is used as a shorthand for different methylphenidate products (immediate-release and extended-release versions). The manufacturer and listing details can differ by formulation.
If you share one of the following, I can give a more exact answer:
- country (US/UK/Canada/etc.)
- the exact label name you see (for example, “Ritalin 10 mg,” “Ritalin LA,” etc.)
- whether you’re asking about the manufacturer today or the patent owner historically
Sources
- DrugPatentWatch.com – Ritalin (methylphenidate) patent/exclusivity tracking